Puff Wealth Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$953K Buy
+3,787
New +$815K 0.97% 31
2025
Q4
$869K Buy
3,788
+20
+0.5% +$4.56K 1.12% 31
2025
Q3
$872K Sell
3,768
-395
-9% -$80.4K 1.33% 27
2025
Q2
$773K Buy
4,163
+15
+0.4% +$2.79K 0.56% 48
2025
Q1
$869K Sell
4,148
-414
-9% -$80.5K 0.81% 36
2024
Q4
$811K Buy
+4,562
New +$839K 1.41% 22

Other funds holding ABBV

Puff Wealth Management's ABBV Position: Q2 2026 in Review

Puff Wealth Management opened a new position in AbbVie (ABBV) in Q2 2026: 3,787 shares worth $953K. The stake represents 0.97% of the portfolio and ranks #31 among its holdings. This is a return to the name: Puff Wealth Management previously reported a position in ABBV as recently as Q4 2025.

Puff Wealth Management first reported a position in ABBV in Q4 2024 and has held it in 6 quarters since. 4,209 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Puff Wealth Management held 3,787 shares of AbbVie worth $953K as of Q2 2026.
  • AbbVie was a new Puff Wealth Management position in Q2 2026.
  • AbbVie made up 0.97% of Puff Wealth Management's portfolio in Q2 2026, its #31 holding.
  • Puff Wealth Management first reported a position in AbbVie in Q4 2024 and has held it in 6 quarters since.
  • 4,209 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Puff Wealth Management's 13F filing for Q2 2026, filed 8 Jul 2026.